Literature DB >> 3655893

Primary cerebellar hemorrhage. Quadrigeminal cistern obliteration on CT scans as a predictor of outcome.

M Taneda1, T Hayakawa, H Mogami.   

Abstract

The authors studied a consecutive series of 75 patients with cerebellar hemorrhage diagnosed by computerized tomography (CT) scanning, and assessed the relationship of outcome to the CT appearance of the quadrigeminal cistern, which in some cases was obliterated by rostral displacement of the vermis resulting from the cerebellar mass. Obliteration of the quadrigeminal cisterns was classified on the CT scans into three grades: normal (Grade I), compressed (Grade II), or absent (Grade III). There were 43 patients with Grade I, 16 with Grade II, and 16 with Grade III cisterns. Of the 75 patients, 38 (88.4%) of those with Grade I, 11 (68.8%) of those with Grade II, and none of those with Grade III cisterns returned to their previous activities at 6 months or more after onset. A Grade I cistern predicted a good outcome whether the hematoma was evacuated or not, as long as obstructive hydrocephalus, if present, was relieved early. However, a Grade II cistern was not predictive of a good outcome unless the hematoma was evacuated within 48 hours after onset of the hemorrhage. A Grade III cistern invariably predicted an unfavorable outcome. It is concluded that the CT grade of quadrigeminal cistern obliteration is an accurate indicator of outcome and is highly useful in selecting appropriate treatment for patients with cerebellar hemorrhage.

Entities:  

Mesh:

Year:  1987        PMID: 3655893     DOI: 10.3171/jns.1987.67.4.0545

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Spontaneous intracerebral haemorrhage.

Authors:  A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Neurosurgical management of cerebellar hemorrhage.

Authors:  E Waidhauser; C Hamburger; F Marguth
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

3.  Spontaneous cerebellar hemorrhage--experience with 57 surgically treated patients and review of the literature.

Authors:  Philipp Dammann; Siamak Asgari; Hischam Bassiouni; Thomas Gasser; Vassilis Panagiotopoulos; Elke R Gizewski; Dietmar Stolke; Ulrich Sure; I Erol Sandalcioglu
Journal:  Neurosurg Rev       Date:  2010-08-10       Impact factor: 3.042

Review 4.  Prognostic factors in the treatment of cerebellar haemorrhage.

Authors:  E Donauer; F Loew; C Faubert; F Alesch; M Schaan
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Management of 50 spontaneous cerebellar haemorrhages. Importance of obstructive hydrocephalus.

Authors:  J J Mezzadri; J M Otero; C A Ottino
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Stereotactic burr hole aspiration surgery for spontaneous hypertensive cerebellar hemorrhage.

Authors:  Jun Hyoung Lee; Dae Won Kim; Sung Don Kang
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28

Review 7.  Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 49 cases and review of the literature.

Authors:  J van Loon; F Van Calenbergh; J Goffin; C Plets
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Neurosurgical management of cerebellar haematoma and infarct.

Authors:  P Mathew; G Teasdale; A Bannan; D Oluoch-Olunya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

9.  Platelet count and early outcome in patients with spontaneous cerebellar hemorrhage: a retrospective study.

Authors:  Ching-Yueh Lin; Chih-Ya Chang; Chia-Hung Sun; Tsung-Ying Li; Liang-Cheng Chen; Shin-Tsu Chang; Yung-Tsan Wu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Prediction of 30-day mortality in spontaneous cerebellar hemorrhage.

Authors:  Diaa Al Safatli; Albrecht Guenther; Aaron Lawson McLean; Albrecht Waschke; Rolf Kalff; Christian Ewald
Journal:  Surg Neurol Int       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.